21 May 2009
Quality of life after kidney and pancreas transplantation
D Zielińska, M DurlikAnn Transplant 2009; 14(1): 45-46 :: ID: 880365
Abstract
Perfused organ transplantation such as transplantation of the whole pancreas
has proved so far to be the best possible way of dealing with type 1 diabetes mellitus. That also includes prevention of its complications. Patients undergoing pancreas-and-kidney surgery are likely to develop post-operative complications, and extensive pharmacological treatment. The likelihood of developing post-operative complications, especially when combined with extensive pharmacological treatment may jeopardize patients' recovery and their quality of life. Recently published data shows, that patients after pancreas and-kidney transplants are likely to have their QoL worse than average in general population, in spite of the fact that they function far better than before the surgery. The aim of this study was to evaluate QoL after pancreas-and kidney transplantation of patients transplanted in our centre. A total of 23 patients were included in the study. Surgical procedures took place between the years 2005 and 2008. In 20 cases pancreas-and-kidney transplant was performed and in 2 cases pancreas transplant was done 2 years after successful kidney transplantation. To evaluate QoL questionnaire QLQ-30 was used, as well as questionnaire BDI (depression assessment) and STAI (anxiety). In all cases the appropriate graft functioning was confirmed.
Results: After at least 6 months following the transplant mean QoL score was 88, mean functioning score was 71.2 and symptoms scale score was 9.1. Average BDI questionnaire score was 8. Four patients have reached 12 points and above. Kidney-and pancreas transplantation significantly improves QoL, although higher scores in anxiety and depression questionnaires are noted.
Keywords: Pancreas Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






